Anthelmintic

5 marketed 2 in Phase 3

This page covers all Anthelmintic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cytochrome P450 1A2, Calcium channels in parasitic flatworms, Nicotinic acetylcholine receptors (nematode-specific).

Targets

Cytochrome P450 1A2 · Calcium channels in parasitic flatworms · Nicotinic acetylcholine receptors (nematode-specific) · Arachidonate 5-lipoxygenase · Beta-tubulin

Marketed (5)

Phase 3 pipeline (2)